Reading the tape
NASDAQ: ARQT
Arcutis Biotherapeutics, Inc.
Healthcare · Biotechnology
Market Cap
$2.94B
52w High
$31.77
52w Low
$12.42
P/E
-186.64
Volume
1.18M
Outstanding Shares
125.07M
Price vs Fundamentals
Why The Stock Is Moving
Fundamentals are supporting the moveModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 52.43%Revenue (TTM): 91.34%FCF (TTM): 94.62%P/S: 45th pct
What changed
The stock rose 52.43% over the last year. Revenue grew 91.34% over the trailing twelve months. Operating margin moved from -65.33% to -3.25%. Free cash flow grew 94.62% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 45th percentile of their historical P/S range.
What would invalidate this read
Operating margin is at -3.25%. Revenue grew 91.34% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
CEOTodd Franklin Watanabe
SectorHealthcare
IndustryBiotechnology
Employees342
IPO dateJan 31, 2020
Valuation
Forward P/E—
EV/EBITDA1,475.09
Enterprise value$3.66B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth81.48%
Gross margin90.24%▼0.03%vs FY2024
Operating margin-3.25%▲95.02%vs FY2024
ROE-8.52%▲90.42%vs FY2024
Analyst consensus
RatingBuy
Target price$35.50▲51.13%
10
Buy
2
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 6, 2026
Q2 FY26 · EPS est -$0.02 · Revenue est $103.68M
View